BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 17678828)

  • 1. The Simplified Disease Activity Index (SDAI) and Clinical Disease Activity Index (CDAI) to monitor patients in standard clinical care.
    Aletaha D; Smolen JS
    Best Pract Res Clin Rheumatol; 2007 Aug; 21(4):663-75. PubMed ID: 17678828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Simplified Disease Activity Index and Clinical Disease Activity Index to monitor patients in standard clinical care.
    Aletaha D; Smolen JS
    Rheum Dis Clin North Am; 2009 Nov; 35(4):759-72, viii. PubMed ID: 19962620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of three rheumatoid arthritis disease activity scores in clinical routine.
    Rintelen B; Sautner J; Haindl PM; Andel I; Maktari A; Leeb BF
    Scand J Rheumatol; 2009; 38(5):336-41. PubMed ID: 19585379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Test-retest reliability of disease activity core set measures and indices in rheumatoid arthritis.
    Uhlig T; Kvien TK; Pincus T
    Ann Rheum Dis; 2009 Jun; 68(6):972-5. PubMed ID: 18957489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Definition of treatment response in rheumatoid arthritis based on the simplified and the clinical disease activity index.
    Aletaha D; Martinez-Avila J; Kvien TK; Smolen JS
    Ann Rheum Dis; 2012 Jul; 71(7):1190-6. PubMed ID: 22454398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rheumatoid arthritis treatment and monitoring of outcomes--where are we [corrected] in 2007?
    Yazici Y; Abramson SB
    Bull NYU Hosp Jt Dis; 2007; 65(4):300-5. PubMed ID: 18081549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RAPID3, an index to assess and monitor patients with rheumatoid arthritis, without formal joint counts: similar results to DAS28 and CDAI in clinical trials and clinical care.
    Pincus T; Yazici Y; Bergman MJ
    Rheum Dis Clin North Am; 2009 Nov; 35(4):773-8, viii. PubMed ID: 19962621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing remission in clinical practice.
    Mierau M; Schoels M; Gonda G; Fuchs J; Aletaha D; Smolen JS
    Rheumatology (Oxford); 2007 Jun; 46(6):975-9. PubMed ID: 17341506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Remission by composite scores in rheumatoid arthritis: are ankles and feet important?
    Kapral T; Dernoschnig F; Machold KP; Stamm T; Schoels M; Smolen JS; Aletaha D
    Arthritis Res Ther; 2007; 9(4):R72. PubMed ID: 17662115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SDAI/CDAI levels in rheumatoid arthritis patients are highly dependent on patient's pain perception and gender.
    Rintelen B; Haindl PM; Maktari A; Nothnagl T; Hartl E; Leeb BF
    Scand J Rheumatol; 2008; 37(6):410-3. PubMed ID: 18759162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DAS28, CDAI and SDAI cut-offs do not translate the same information: results from the Rheumatic Diseases Portuguese Register Reuma.pt.
    Martins FM; da Silva JA; Santos MJ; Vieira-Sousa E; Duarte C; Santos H; Costa JA; Pimentel-Santos FM; Cunha I; Cunha Miranda L; Nóvoa T; Cruz M; Bernardes M; Araujo D; Pereira Silva JA; Silva JC; Branco JC; Gomes JA; Faustino A; Fonseca JE; Canhão H
    Rheumatology (Oxford); 2015 Feb; 54(2):286-91. PubMed ID: 25173347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of disease activity and health status cut-off points for the symptom state acceptable to patients with rheumatoid arthritis.
    Heiberg T; Kvien TK; Mowinckel P; Aletaha D; Smolen JS; Hagen KB
    Ann Rheum Dis; 2008 Jul; 67(7):967-71. PubMed ID: 17965118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How should rheumatoid arthritis disease activity be measured today and in the future in clinical care?
    Sokka T
    Rheum Dis Clin North Am; 2010 May; 36(2):243-57. PubMed ID: 20510232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic monitoring of disease activity using an outcome measure improves outcomes in rheumatoid arthritis.
    Katchamart W; Bombardier C
    J Rheumatol; 2010 Jul; 37(7):1411-5. PubMed ID: 20436069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proposed metrics for the determination of rheumatoid arthritis outcome and treatment success and failure.
    Wolfe F; Michaud K
    J Rheumatol; 2009 Jan; 36(1):27-33. PubMed ID: 19040313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The rheumatoid arthritis disease activity index-5 in daily use. Proposal for disease activity categories.
    Rintelen B; Haindl PM; Sautner J; Leeb BA; Deutsch C; Leeb BF
    J Rheumatol; 2009 May; 36(5):918-24. PubMed ID: 19332635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patients with moderate rheumatoid arthritis (RA) achieve better disease activity states with etanercept treatment than patients with severe RA.
    Keystone E; Freundlich B; Schiff M; Li J; Hooper M
    J Rheumatol; 2009 Mar; 36(3):522-31. PubMed ID: 19228659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Established rheumatoid arthritis: clinical assessments.
    van Riel PL; Fransen J
    Best Pract Res Clin Rheumatol; 2007 Oct; 21(5):807-25. PubMed ID: 17870029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generic quality-of-life assessment in rheumatoid arthritis.
    Tugwell P; Idzerda L; Wells GA
    Am J Manag Care; 2007 Dec; 13 Suppl 9():S224-36. PubMed ID: 18095786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reliability, validity and responsiveness of a new leisure index: the Patient-Specific Leisure Scale (PSLS).
    Wikström I; Arvidsson B; Nilsson K; Roos E; Jacobsson LT
    Musculoskeletal Care; 2009 Sep; 7(3):178-93. PubMed ID: 19191254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.